To test whether β2.7 modulates ROS levels during a latent infection, we mock infected or infected CD14+ monocytes with WT or Δβ2.7 Toledo virus for 6 days and then treated them with cadmium chloride. The gene discussed is CD14; the disease is disease arising from reactivation of latent virus.